Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -16.840% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. c1ccc(-n2nnc3c(N4CCOCC4)ncnc32)cc1
b. CC1CCCC(C)N1C(=O)CSc1nc(N)c(-c2ccccc2)c(=O)[nH]1
c. O=C(CC(=O)Nc1ccc(Br)cc1)Nc1ccc(Br)cc1
d. Cc1cc(C)cc(NC(=O)C(=O)NCC2CCCN2S(=O)(=O)c2cccs2)c1
Answer: a. c1ccc(-n2nnc3c(N4CCOCC4)ncnc32)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(-n2nnc3c(N4CCOCC4)ncnc32)cc1
c1ccc(-n2nnc3c(N4CCOCC4)ncnc32)cc1
4-(3-phenyltriazolo[4,5-d]pyrimidin-7-yl)morpholine